An analysis of the effect of statins on the risk of Non‐Hodgkin's Lymphoma in the Women’s Health Initiative cohort
Abstract Statins have been shown to induce a phosphoprotein signature that modifies MYC (myelocytomatosis viral oncogene) activation and to have anti‐inflammatory activity that may impact the risk of Non‐Hodgkin's lymphoma (NHL). We analyzed the relationship between statins and risk of NHL usin...
Main Authors: | Pinkal Desai, Robert Wallace, Matthew L. Anderson, Barbara V. Howard, Roberta Ray, Chunyuan Wu, Monika Safford, Lisa W. Martin, Nicolas Schlecht, Simin Liu, Dominic Cirillo, Allison Jay, JoAnn E. Manson, Michael S. Simon |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-05-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.1368 |
Similar Items
-
Actual questions of endoscopic diagnostic of non-Hodgkin lymphoma of stomach
by: O. A. Malikhova, et al.
Published: (2022-11-01) -
Epidemiology of Non-Hodgkin’s Lymphoma
by: Krishna C. Thandra, et al.
Published: (2021-01-01) -
Efficacy and safety of biosimilar rituximab (ZytuxTM) in newly diagnosed patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia
by: Alaa Fadhil Alwan, et al.
Published: (2020-12-01) -
Rapidly Progressing Non-Hodgkin’s Lymphoma of Thyroid Gland
by: Madhusmita Patnaik, et al.
Published: (2024-04-01) -
IEV (Ifosfamide, Epirubicin, VP16) Regimen as Salvage Therapy for Early Relapsed/Refractory non-Hodgkin/Hodgkin Lymphoma
by: Mohammadali Mashhadi, et al.
Published: (2011-09-01)